Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: Cincor pharma - You Need To See This

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022

Upgrades

Benzinga · Aug 22, 2022

$18 Million Bet On This Biotechnology Stock? 4 Stocks Insiders Are Buying

Although US stocks closed lower on Wednesday following the release of Fed minutes, there were a few notable insider trades.

Benzinga · Aug 18, 2022

Insiders Buy Around $70M Of 4 Stocks: Six Flags Entertainment, MGM Resorts And More

Although US stocks closed higher on Monday, there were a few notable insider trades.

Benzinga · Aug 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Aug 8, 2022

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Benzinga · Jul 26, 2022

CinCor Pharma Begins Patient Dosing In Midstage Hypertension, Kidney Disease Study

CinCor Pharma (NASDAQ: CINC) has dosed first patient in the figHTN-CKD Phase 2 clinical study of its drug candidate Baxdrostat (CIN-107) for the treatment of patients with uncontrolled hypertension and chronic kidney disease (CKD).

Benzinga · Jun 1, 2022

CinCor Pharma Q4 2021 Earnings Conference Call On March 22, 2022 At 08:30 AM ET

CinCor Pharma (NASDAQ:CINC) will host a conference call at 08:30 AM ET on March 22, 2022, to discuss Q4 2021 earnings results.

Benzinga · Mar 17, 2022

Read news from The Economist, FT, and more,
with one subscription

CinCor Pharma's Ex-Dividend Date Is Sunday, Here's What You Need To Know

Sunday marks the last chance for investors to receive the next dividend payout from CinCor Pharma.

Benzinga · Jan 19, 2022

Coverage From

Benzinga

Organisations

United Parcel Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Amyotrophic lateral sclerosis

35 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.